Self-guided mobile app for stress reduction in depression shows modest benefit
A randomized controlled trial of 36 adults with mild-to-moderate depression found that a 4-week self-guided digital intervention combining cognitive-behavioral therapy and mindfulness reduced stress scores by a clinically meaningful amount when used alongside standard antidepressant medication.
Stress and depression reinforce each other, yet accessible stress management tools during early pharmacological treatment remain scarce. Researchers conducted a multicenter, assessor-blinded randomized crossover pilot trial to test whether inMind—a self-guided digital app combining cognitive-behavioral therapy, mindfulness-based stress reduction modules, relaxation audio, and heart-rate-variability stress monitoring—could reduce stress in 36 adults (baseline ages not specified) with mild-to-moderate major depressive disorder already taking antidepressants.
Over 4 weeks, participants using the app showed a reduction in stress scores of 2.41 points on the Depression Anxiety Stress Scales-Stress subscale (p = 0.047), narrowly exceeding the published minimum clinically important difference; reductions in depression and anxiety symptoms moved in the same favorable direction. A significant limitation was carry-over effects in the crossover design without a washout period, which complicates causal interpretation—outcomes might reflect habit or expectancy rather than the app itself. Usage time showed no significant link to outcomes, suggesting benefit may not require intensive engagement. Adherence rates were high in both study groups, indicating acceptable acceptability of the tool.
The crossover design without washout is a notable weakness: participants in the delayed-app group may have retained benefits from the first arm, inflating apparent efficacy in the active phase. The lack of association between app usage time and outcomes is intriguing—it suggests that even low-intensity, flexible engagement (users could dip in and out) was sufficient, rather than requiring daily, structured use. This contrasts with some digital interventions that demand high adherence to show benefit. Subgroup analyses by depression severity, symptom profile, or medication type were not reported; it remains unclear whether mild versus moderate MDD responds differently. The trial was powered as a pilot, so the narrow p-value (0.047) and small effect size warrant cautious interpretation. If confirmed in a fully powered, longer-duration trial, the finding would support inMind as a low-barrier adjunct, especially valuable for patients in geographies or time zones where therapist access is limited.
The deeper explanation, the effect sizes and caveats, and what this means for your own sleep, exercise and reading — read it inside Cadence.
Open in Cadence →References
- Preliminary efficacy of a self-guided mobile intervention for reducing stress in depression: A randomized controlled crossover trial. — Journal of affective disorders (Read the original)